· 5 stocks
Japan's hydrogen-ammonia push has three converging structural drivers in 2026. First, the February 2026 Iran conflict and Strait of Hormuz closure exposed the severity of Japan's oil import dependence (93-95% of crude from Middle East, ~74% transiting Hormuz) and forced an emergency reserves release of 80 million barrels. METI established an Iran Situation Energy Response Headquarters and accelerated the Seventh Strategic Energy Plan, which targets raising the fossil-fuel self-development ratio from 37% to 60%+ by 2040. Second, Japan's GX (Green Transformation) plan — ¥150 trillion in public-private investment over 10 years — allocates ¥15 trillion specifically to the hydrogen-ammonia supply chain, supported by ¥3 trillion in CfD price-gap subsidies under the 2023 Hydrogen Society Promotion Act. December 2025 marked the first CfD certifications: JERA and Mitsui were approved for 772,000 tonnes/year of blue ammonia from Louisiana's Blue Point facility (CF Industries), underpinning Japan's 3 million tonne/year ammonia import target by 2030. Third, JERA achieved the world's first commercial-scale 20% ammonia co-firing test at Hekinan Unit 4 (1 GW) in April 2024, validating the technology path. Commercial 20% co-firing at Hekinan targets FY2029, scaling to 50% co-firing demonstration by ~2028. Japan aims for hydrogen + ammonia to reach 10% of electricity generation by 2050. Japan is the only nation with a commercially demonstrated ammonia co-firing programme at large scale and has built the world's first liquid hydrogen import supply chain (Suiso Frontier, Kawasaki-Brunei 2020). The supply chain from overseas green/blue ammonia production through specialist carriers to co-firing power plants is the key investment arc for the decade to 2035. Sources: METI Basic Hydrogen Strategy June 2023; S&P Global JERA/Mitsui CfD Dec 2025; Ammonia Energy Association JERA Hekinan; CSIS Iran conflict Japan analysis Apr 2026.
Portfolio Overview
| # | Company | Conv | Wt | PE | Fwd PE | PB | ROE | OpMar | D/E | DY | FCF |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Iwatani Corporation8088.T | HIGH | 30% | 11.50 | N/A | 1.02 | 13.4% | ~6.0% | N/A | N/A | N/A |
| 2 | Mitsui O.S.K. Lines9104.T | HIGH | 28% | 7.60 | N/A | 0.78 | 10.0% | 18.1% | N/A | N/A | N/A |
| 3 | JGC Holdings1963.T | MEDIUM | 22% | 17.80 | N/A | 1.39 | 8.2% | ~5.0% | N/A | N/A | N/A |
| 4 | Chiyoda Corporation6366.T | MEDIUM | 15% | 13.10 | N/A | N/A | N/A (distorted) | 9.3% | N/A (net cash ¥142B) | N/A | N/A |
| 5 | Nippon Shokubai4114.T | LOW | 5% | 20.20 | N/A | N/A | 4.9% | ~5.5% | N/A | N/A | N/A |
Portfolio Construction
Stock-by-Stock Analysis
Iwatani Corporation
8088.THIGHCoreWeight: 30%
Why this stock
Iwatani is Japan's sole fully-integrated hydrogen company — the only entity spanning liquefaction, transportation, and retail refueling. Its 51-station Japan network (34% national share vs. nearest competitor's <10 stations) creates durable network effects: hydrogen vehicle buyers choose routes that have Iwatani stations, which anchors Toyota/Honda FCEV rollout economics. The ¥178 billion hydrogen capex over 5 years (38% of total ¥470B) is the highest capex-intensity hydrogen commitment of any listed Japanese company. Strategic partner to Toyota, Honda, and Nissan via JHyM consortium. Valuation at PE 11.5x and PB ~1x offers a margin of safety rare in clean-energy infrastructure.
What could go wrong
1) Japan's hydrogen station count declined in 2024 (149 from 151) — Japan is far behind the 581-station 2025 interim target and the 1,321-station 2030 goal. If FCEV adoption stalls, 51-station network becomes stranded capex. 2) Net margin compressed from ~6% to ~4.3% in latest data — LPG/industrial gas margins under pressure as energy mix shifts. 3) Hydrogen is still <15% of revenue; core LPG business exposed to oil price normalization after Hormuz tensions ease.
Monitoring trigger
If Japan hydrogen station network falls below 140 stations (net closures accelerating), TRIM. If FCEV parc exceeds 50,000 vehicles nationally by end-2027 and Iwatani station utilization >30%, ADD. Watch annual hydrogen capex commitment in FY2027 plan (due Nov 2026).
Mitsui O.S.K. Lines
9104.THIGHCoreWeight: 28%
Why this stock
MOL owns the most comprehensive hydrogen/ammonia maritime portfolio of any listed company: the Suiso Frontier (world's first liquid hydrogen carrier), three ammonia-powered Capesize bulkers delivering 2026-27 (co-owned with CMB.TECH), and AiP for a large ammonia-powered ammonia carrier (March 2025). The JERA-Mitsui Louisiana CfD project (certified Dec 2025) creates a confirmed freight demand pull: 500,000 t/year of blue ammonia commencing February 2030 for Hekinan needs dedicated carriers — and MOL is the most logical operator. Valuation is compelling at PB 0.78x (below book) and PE 7.6x with 18.1% operating margin, reflecting the market treating MOL as ex-growth shipping rather than an infrastructure play on the ammonia trade.
What could go wrong
1) PEAK EARNINGS FLAG: MOL's ONE JV (container shipping, 31% stake) generated exceptional profits 2021-2023; container rates have normalized and ONE equity income will likely decline further. PE 7.6x may not be as cheap as it looks if normalized earnings power is lower. 2) Ammonia freight revenues are 2030+ (pre-commercial revenue is effectively zero from H2/NH3 today). 3) Shipping rates are cyclical; bulk shipping downturn would pressure core business independent of ammonia thesis. 4) Scale of ammonia carrier fleet required for 3Mt/yr 2030 import target far exceeds current Japan-operated fleet.
Monitoring trigger
FY2026 annual results (May 2026) — watch ONE equity income trajectory and management guidance for ammonia carrier orders. If MOL announces a concrete ammonia carrier order for JERA/Mitsui Louisiana supply chain (expected 2026-27), ADD. If ONE JV income falls >30% without offsetting ammonia freight backlog, TRIM.
JGC Holdings
1963.TMEDIUMSatelliteWeight: 22%
Why this stock
JGC is Japan's leading LNG-focused EPC contractor, uniquely positioned at the intersection of legacy LNG infrastructure (where Japan's energy security dollars are flowing) and new ammonia/hydrogen engineering. January 2026: JGC started ammonia production at the Namie, Fukushima demonstration plant (NEDO-funded, renewable energy powered) — one of the world's first green ammonia production plants. April 2025: ammonia cracking partnership with Amogy (US) to develop large-scale crackers. EPC backlog is the strongest in a decade: Papua LNG (TotalEnergies, 4 MTPA, FID pending 2026), INPEX Masela (FEED signed Aug 2025), LNG Canada Phase 2 (FEED with Fluor, Aug 2025), and an FLNG project (Jul 2025). These projects will absorb capacity 2026-2030 and compound into higher-margin repeat work.
What could go wrong
1) H2/NH3 revenue is <5% — concept stock risk; mitigated by Namie plant operational and Amogy partnership. 2) Papua LNG FID requires TotalEnergies capex commitment in a period of energy transition uncertainty; if delayed beyond 2027, earnings ramp is deferred. 3) EPC gross margins are thin (~3-5%); cost overruns on mega-projects (common historically) can erase profits. 4) FX exposure: JGC contracts in USD, costs partially JPY — yen strengthening hurts reported margins.
Monitoring trigger
Papua LNG FID announcement (expected 2026-27) — if awarded to JGC/Hyundai E&C JV, ADD. If FID delayed beyond Dec 2027, TRIM. Watch FY2026 H2 results for operating profit >¥30B — signals margin recovery from trough.
Chiyoda Corporation
6366.TMEDIUMSatelliteWeight: 15%
Why this stock
Chiyoda's SPERA Hydrogen system is the world's ONLY commercial-scale LOHC (Liquid Organic Hydrogen Carrier) technology using methylcyclohexane (MCH) — proven in the world's first international hydrogen supply chain demonstration (Brunei→Kawasaki, 2020). SPERA's advantage: MCH can be shipped in existing chemical tankers without cryogenic infrastructure, slashing transport costs vs liquid hydrogen. Commercial scale: Chiyoda + Mitsubishi Corporation + Port of Rotterdam targeting 100-400 kt/year H2 imports via Rotterdam by 2026-2027. Net cash of ¥142B provides balance sheet runway through the commercialization bridge. Core LNG EPC business (INPEX, Qatargas relationships) funds the SPERA investment, creating a cash-generating base with a free technology option.
What could go wrong
1) CONCEPT STOCK FLAG: SPERA hydrogen revenue is <5% of total. This is a call option on commercialization, not current revenue. 2) Competing LOHC technologies (Hydrogenious/DBT chemistry in Germany; Chinese LOHC entrants) could reach commercial scale before SPERA Rotterdam — first-mover advantage is not guaranteed. 3) Stock +210% in 52 weeks on LNG project cycle recovery — valuation has run ahead of fundamentals. Revenue declined 9.7% YoY. 4) ROE of 124% is mathematically distorted by near-zero retained equity base — not a quality signal. Use net cash (¥142B) as balance sheet anchor instead.
Monitoring trigger
Rotterdam SPERA commercial operation announcement (targeted 2026-2027): if first MCH shipment confirmed, ADD (thesis inflection). If Rotterdam project is delayed beyond 2027, TRIM (SPERA commercialization at risk). FY2026 results: if LNG EPC operating margin recovers above 8%, base thesis improves.
Nippon Shokubai
4114.TLOWTacticalWeight: 5%
Why this stock
Nippon Shokubai's ammonia cracking catalyst R&D is a high-risk but genuinely differentiated technology bet. Conventional low-temperature ammonia cracking catalysts require expensive noble metals (ruthenium, iridium). Nippon Shokubai, partnered with MHI under NEDO's competitive funding programme (October 2025), is developing a noble-metal-free catalyst matching performance at lower cost — a potential breakthrough for the economics of blue/green ammonia-to-hydrogen systems. If the FY2027 demonstration proves durability, Nippon Shokubai could supply catalysts to every ammonia cracking plant built globally after 2028. Base business (acrylic acid, superabsorbent polymers) is stable and FCF-positive, providing a floor. At PE 20x, the market is not pricing any hydrogen optionality.
What could go wrong
1) CONCEPT STOCK FLAG: hydrogen/ammonia revenue <2% of total. The NEDO R&D is through FY2027 — commercialization is 2028+ at earliest. This is a 5% speculative allocation only. 2) Catalyst durability under real-world conditions (heat cycling, contaminants) often fails in scale-up. Noble-metal-free does not guarantee commercialization. 3) MHI is both a partner and potential competitor — if MHI develops its own catalyst technology as part of the JV, Nippon Shokubai's proprietary position may be eroded. 4) Core acrylic acid and SAP margins are structurally pressured by Chinese capacity expansion.
Monitoring trigger
FY2027 NEDO demonstration results (expected late 2027): if catalyst meets durability targets over 5,000-hour test cycle, UPGRADE conviction. If MHI breaks the JV or files independent patents on cracking catalysts, EXIT. PE re-rating above 25x on H2 hype without commercial revenue = TRIM.
AI-generated for research purposes only. NOT investment advice. Generated .